RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
BRCA1 dysfunction sensitizes cancer cells to PARP inhibitors (PARPi) but the underlying mechanism is unclear. Here, the authors identify RNF19A as a determinant of PARPi sensitivity, showing that RNF19A ubiquitinates BARD1, negatively regulates the BRCA1-BARD1 complex, and inhibits homologous recomb...
Guardado en:
Autores principales: | Qian Zhu, Jinzhou Huang, Hongyang Huang, Huan Li, Peiqiang Yi, Jake A. Kloeber, Jian Yuan, Yuping Chen, Min Deng, Kuntian Luo, Ming Gao, Guijie Guo, Xinyi Tu, Ping Yin, Yong Zhang, Jun Su, Jiayi Chen, Zhenkun Lou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d742e4b0a47046059d6a6abb06c3fe44 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage
por: John J. Krais, et al.
Publicado: (2021) -
A synergetic effect of BARD1 mutations on tumorigenesis
por: Wenjing Li, et al.
Publicado: (2021) -
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
por: Yinghua Zhu, et al.
Publicado: (2018) -
p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability
por: Longtao Wu, et al.
Publicado: (2020) -
Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
por: Klaudia Stempa, et al.
Publicado: (2021)